Incidence of bloodstream infections in a speciality hospital in Kuwait: 8-Year experience

Medical Principles and Practice

Volumn 14, Issue 6, 2005, Pages 417-421

  Dimitrov, T S ^a,c   Panigrahi, D ^b   Emara, M ^a   Al Nakkas, A ^a   Awni, F ^a   Passadilla, R ^a  

^a Infectious Diseases Hospital Kuwait   (Kuwait)

^b KUWAIT UNIVERSITY   (Kuwait)

^c IDH Lab Department   (Kuwait)

Author keywords

Antimicrobial susceptibility; Bloodstream infections; Frequency of isolation

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; ANTIINFECTIVE AGENT; BETA LACTAMASE; CEFALOTIN; CEFTRIAXONE; CEFUROXIME; CIPROFLOXACIN; GENTAMICIN; PIPERACILLIN; PIPERACILLIN PLUS TAZOBACTAM;

ADULT; ANTIBIOTIC SENSITIVITY; ANTIMICROBIAL ACTIVITY; ARTICLE; BACTEREMIA; BLOOD CULTURE; BLOOD FLOW; BRUCELLA; CHILD; CONTROLLED STUDY; DEMOGRAPHY; DIFFUSION; ENZYME SYNTHESIS; HOSPITAL; HUMAN; INFECTION; KUWAIT; MEDICAL RECORD; MINIMUM INHIBITORY CONCENTRATION; MULTIDRUG RESISTANCE; NONHUMAN; SALMONELLA; SALMONELLA ENTERICA; SALMONELLA PARATYPHI; SALMONELLA TYPHI; SEPTICEMIA; SEROTYPE; STATISTICAL SIGNIFICANCE;

ADOLESCENT; ADULT; AGED; BACTEREMIA; BACTERIA; CHILD; CHILD, PRESCHOOL; HOSPITALS, SPECIAL; HUMANS; INCIDENCE; INFANT; KUWAIT; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED;

EID: 26644436485     PISSN: 10117571     EISSN: None     Source Type: Journal    
DOI: 10.1159/000088115     Document Type: Article

References (26)

1. Reimer LG, Wilson ML, Weinstein MP: Update on detection of bacteremia and fungemia. Clin Microbiol Rev 1997;10:444-465.
2. Washington JA: Blood cultures: an overview. Eur J Clin Microbiol Infect Dis 1989;8:803-806.
3. Spencer RC: Blood cultures: where do we stand? J Clin Pathol 1988;41:668-670.
4. Haug JB, Harthug S, Kalager T, Digranes A, Solberg CO: Bloodstream infections at a Norwegian University Hospital, 1974-1979 and 1988-1989: changing etiology, clinical features, and outcome. Clin Infect Dis 1994;19:246-256.
5. Decousser JW, Pina P, Picot F, Delalande C, Pangon B, Courvalin P, Allouch P: Frequency of isolation and antimicrobial susceptibility of bacterial pathogens isolated from patients with bloodstream infections: a French prospective national survey. J Antimicrob Chemother 2003;51:1213-1222.
6. Reacher MH, Shah A, Livermore DM, Wale MC, Graham C, Johnson AP, Heine H, Monnickendam MA, Barker KF, James D, George RC: Bacteraemia and antibiotic resistance of its pathogens reported in England and Wales between 1990 and 1998: trend analysis. BMJ 2000;320:213-216.
7. Panigrahi D, al-Aneziz AH, West PW: Plasmid-mediated multidrug resistance in Salmonella typhi in Kuwait. Trop Med Int Health 1996;1:439-442.
8. Panigrahi D, Chugh TD, West PWJ, Dimitrov TS, Groover S, Mehta G: Antimicrobial susceptibility, phage typing and plasmid profile of Salmonella enterica serotype paratyphi A strains isolated in Kuwait. Med Princ Pract 2003;12:252-255.
9. Dimitrov TS, Panigrahi D, Emara E, Awni F, Passadilla R: Seroepidemiological and microbiological study of Brucellosis in Kuwait. Med Princ Pract 2004;13:215-219.
10. Weinstein MP: Current blood culture methods and systems: clinical concepts, technology and interpretation of results. Clin Infect Dis 1996;23:40-46.
11. Murray PK, Baron EJ, Jurgensen JH, Pfaller MA, Yolken RH: Manual of Clinical Microbiology, ed 8. Washington, American Society for Microbiology 2003, p 1212.
12. National Committee for Clinical Laboratory Standards: Methods for Disk Susceptibility Tests for Bacteria That Grow Aerobically, ed 7. NCCLS Document M2-A7. Wayne, National Committee for Clinical Laboratory Standards, 2003.
13. Cormican MG, Marshall SA, Jones RN: Detection of extended spectrum beta-lactamase producing strains by E-test screen. Clin Microbiol 1996;34:1880-1884.
14. Reimer LG, Wilson ML, Weinstein MP: Update on detection of bacteremia and fungemia. Clin Microbiol Rev 1997;10:444-465.
15. Mycotte JM, Tayara A: Blood culture: clinical aspects and controversies. Eur J Clin Microbiol Infect Dis 2000;19:157-163.
16. Chandrasekar PH, Brown MJ: Clinical issues of blood cultures. Arch Intern Med 1994;154:841-849.
17. Fluit AC, Jones MF, Schmitz FJ, Gupta R, Verhoef J: Antimicrobial susceptibility and frequency of occurrence of clinical blood isolates in Europe from the SENTRY antimicrobial surveillance program, 1997 and 1998. Clin Infect Dis 2000;30:454-460.
18. Diekema DJ, Pfaller MA, Jones RN, Doem GV, Kugler KC, Reach ML: Trends in antimicrobial susceptibility of bacterial pathogens isolated from patients with bloodstream infections in the USA, Canada and Latin America SENTRY participants group. Int J Antimicrob Agents 2000;13:257-271.
19. Banerjee SN, Emori TG, Culver DH: Secular trends in nosocomial primary bloodstream infections in the United States, 1980-1989: National Nosocomial Infectious Surveillance System. Am J Med 1991;91(suppl 3B):86S-89S.
20. Gatell JM, Trilla A, Latorre X: Nosocomial bacteremia in a large Spanish teaching hospital: analysis of factors influencing prognosis. Rev Infect Dis 1988;10:203-210.
21. Stillman RI, Wenzel RP, Donowitz LC: Emergence of CNS as major nosocomial bloodstream pathogens. Infect Control 1987;8:108-112.
22. Mirrett S, Weinstein MP, Reimer LG, Wilson ML, Reller LB: Interpretation of coagulase-negative staphylococci in blood cultures: does the number of positive bottles help? (abstract C69). Program and Abstracts of the 93rd General Meeting of the American Society for Microbiology, Atlanta, 1993, p 458.
23. Peacock SJ, Bewler ICJW, Crook DWM: Positive predictive value of blood cultures growing coagulase-negative staphylococci (letter). Lancet 1995;346:191-192.
24. Chandel DS, Chaudhry R, Dhawan B, Pandey A, Dey AB: Drug-resistant Salmonella enterica serotype paratyphi A in India. Emerg Infect Dis 2000;6:420-421.
25. Threlfall EJ, Ward LR: Decreased susceptibility to ciprofloxacin in Salmonella enterica serotype typhi, United Kingdom. Emerg Infect Dis 2001;7:448-450.
26. Poutanen SM, Low DE: Is it time to change fluoroquinolone MIC breakpoints for Salmonella spp.? Clin Microbiol Newsl 2003;25:97-102.